Wavegate is pleased to announce that John Tattory has assumed the role of interim CFO. After several years in the CFO role at Wavegate, Mr. Robert Ehlers is changing roles to an advisor at Wavegate to allow him to concentrate on his core business. We thank Robert for his service and look forward to John's tenure in this strategic role.
More about John:
John Tattory currently serves as a Senior Consultant at LifeSci Associates, a firm specializing in interim C-suite consultants for the life science industry.
Mr. Tattory has over 25 years of financial leadership experience primarily in the biotechnology and life sciences sectors. He has broad-based, public and private company financial leadership experience directing U.S. and international financial operations, executing strategic transactions, raising capital through equity and debt financings, and managing investor relations. Prior to joining LifeSci Associates, John served as Chief Financial Officer at Cerapedics Inc., a privately held, ortho-biologics company focused on developing and commercializing its proprietary technology platform to enhance the science of bone repair and Windtree Therapeutics, a publicly-traded, biotechnology company focused on the development of novel therapeutics intended to address acute cardiovascular and pulmonary diseases. Mr. Tattory has raised over $400 million in capital through public and private equity offerings, structured debt facilities and licensing agreements. He previously held financial management positions at Bristol-Myers Squibb and Ernst & Young LLP. John is a certified public accountant (currently inactive status) and holds a B.S. in Commerce degree from Rider University.